anti-CD48 mAb (Osaka University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD48 mAb (Osaka University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCluster of differentiation 48 inhibitors
TargetsCluster of differentiation 48
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsaka University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsaka University
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A